-
LORANIB lorlatinib 25mg 30'S Approval No. 11 L 0935/22 Expiration Date 05-12-2025
Regular price ¥550.00 CNYRegular priceUnit price per¥2,000.00 CNYSale price ¥550.00 CNYSale -
LORANIB lorlatinib 100mg 30'S Approval No. 03 L 0956/23 Expiration Date 04-4-2026
Regular price ¥1,125.00 CNYRegular priceUnit price per¥3,000.00 CNYSale price ¥1,125.00 CNYSale -
Lorlatinib 25mg, LORLADX, Lorlatinib,
Regular price ¥600.00 CNYRegular priceUnit price per¥800.00 CNYSale price ¥600.00 CNYSale -
Lorlatinib 25mg for the treatment of non-small cell lung cancer
Regular price ¥520.00 CNYRegular priceUnit price per¥800.00 CNYSale price ¥520.00 CNYSale -
Lorlatinib 100mg, LORLADX, Lorlatinib
Regular price ¥1,320.00 CNYRegular priceUnit price per¥2,500.00 CNYSale price ¥1,320.00 CNYSale -
Lorlatinib 100mg for the treatment of non-small cell lung cancer
Regular price ¥1,200.00 CNYRegular priceUnit price per¥2,500.00 CNYSale price ¥1,200.00 CNYSale -
Lorlatinib 25mg
Regular price ¥450.00 CNYRegular priceUnit price per -
SaleLorlatinib 100mg
Regular price ¥1,125.00 CNYRegular priceUnit price per¥2,500.00 CNYSale price ¥1,125.00 CNYSale -
LORLAMAKS25 Drug name: Lorlatinib tablets/Lorlatinib
Regular price ¥600.00 CNYRegular priceUnit price per -
PHOLORLA 25 Drug name: PHOLORLA 25 Generic name: Lorlatinib tablets/Lorlatinib
Regular price ¥1,500.00 CNYRegular priceUnit price per -
Alectinib 150mg 56TABLES Approval No. 08 L 0811/19 Expiration Date 06-9-2025
Regular price ¥1,800.00 CNYRegular priceUnit price per¥3,000.00 CNYSale price ¥1,800.00 CNYSale -
Alectinib is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
Regular price ¥1,275.00 CNYRegular priceUnit price per¥1,800.00 CNYSale price ¥1,275.00 CNYSale -
LORLATINIB 100MG 30'S Approval No. 03 L 0849/21 Validity Date 06-8-2027
Regular price ¥1,350.00 CNYRegular priceUnit price per¥3,000.00 CNYSale price ¥1,350.00 CNYSale
